Obesity Trial, Recruiting NCT07313293 Sponsor: Centre Hospitalier Departemental Vendee Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT07313293
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults (18 years of age or older)
  • People who are scheduled to have a sleeve gastrectomy (a type of weight-loss surgery that removes part of the stomach)
  • People who are able to understand the study and have given verbal agreement to take part
  • People who are covered by, or entitled to benefits under, a social security system

Who may not be able to join:

  • People who are on long-term morphine or opioid (strong painkiller) medication
  • People who have a blood clot in a vein (phlebitis), a wound on the foot, or a recent foot injury such as one requiring a cast or splint
  • People who are under guardianship, curatorship, or who are currently detained or imprisoned
  • People who are pregnant, breastfeeding, or who do not wish to use contraception
  • People who are already taking part in another clinical research study that could affect the results of this one
  • People who are subject to an activated future protection mandate (a legal arrangement made in advance for someone who may lose decision-making capacity) (confirm with trial site)
  • People who are subject to a family authorisation arrangement (confirm with trial site)
  • People who are under judicial protection (a legal protective measure ordered by a court) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Emeric ABET, Centre Hospitalier Departemental Vendee

Phone: 251446327

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier Departemental Vendee
Registry
ClinicalTrials.gov
Start date
1 April 2026
Est. completion
2 April 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Number of patients experiencing significant nausea and/or vomiting (with a score ≥ 3 on a numerical scale of 0 to 10) within 24 hours post-operatively

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov